The Holistic Pharmacy Approach To 340B Patient Support

September 8, 2025340B, Bedside Prescription Delivery, Contract Pharmacy, Drug Manufacturer Restrictions, Meds To Beds, Patient Eligibility, PBM, Readmissions Reduction, Retail / Outpatient Pharmacy, Specialty Drugs, Specialty Pharmacy, Uncategorized, Value-Based Care

How to make Pharmacy “The Easy Part” of the patient experience. Anyone who’s ever been a hospital patient, or patient caregiver, knows that the mental strain of a serious illness can often match the negative impact of the physical trauma. Particularly when an illness is chronic and/or long-term, the stress involved in managing the details … Read More

Why A 340B Hospital Should Own A Specialty Pharmacy. Why Not.

July 8, 2025340B ESP, Bedside Prescription Delivery, Contract Pharmacy, PBM, Readmissions Reduction, Retail / Outpatient Pharmacy, Specialty Drugs, Specialty Pharmacy, TPA / TPAs

Before we begin, we’re going to be honest with you. A significant component of VytlOne’s business is guiding 340B health systems through the process of building, accrediting, funding, launching and managing on-campus specialty pharmacies. Many times in this space, we’ve maintained that every 340B hospital should consider owning a specialty pharmacy. We’re currently in the … Read More

How To Use Your 340B Program As a Community Health Engine

May 13, 2025340B, PBM, Prescription Discounts, Readmissions Reduction, Retail / Outpatient Pharmacy, Specialty Drugs, Value-Based Care

We all know the 340B Drug Pricing Program was designed to enable eligible healthcare organizations to stretch scarce federal resources in serving underserved patients and expanding their missions in the community services. What we at VytlOne have learned in supporting the 340B programs of more than 100 health systems and health centers is that, properly … Read More

The Pharmacy Model That Restores Control To 340B Hospitals

January 24, 2025340B, Drug Manufacturer Restrictions, Prescription Discounts, Retail / Outpatient Pharmacy, Specialty Drugs, Specialty Pharmacy

How your health system can leverage visibility, your PBM and your pharmacies to achieve your financial and clinical goals.   The systemic problem: Overview The U.S. prescription drug market is a textbook case of waste and inefficiency — one that, in recent years, has disproportionately benefited a handful powerful corporations at the expense of providers, … Read More

Optimize Your Health System’s Patient Care & ROI With 340B

August 7, 2024340B, 340B ESP, Compliance, Contract Pharmacy, Covered Entities, Drug Manufacturer Restrictions, Meds To Beds, Patient Eligibility, Prescription Discounts, Readmissions, Retail / Outpatient Pharmacy, Specialty Drugs, Specialty Pharmacy, Specialty Pharmacy, TPA / TPAs

Far too many 340B hospitals overlook pharmacy’s overall potential in their health systems’ revenue cycles. Below is a graphic overview of VytlOne’s integrated approach to optimizing a health system’s pharmacy services, savings and revenue. In 340B support alone, we’ve generated over $500 million for the hospitals we serve — revenue those systems have used to … Read More

Empower Your Health System’s 340B Program With Analytics

July 10, 2024340B, Compliance, Contract Pharmacy, Covered Entities, Drug Manufacturer Restrictions, Medication Compliance, Patient Eligibility, TPA / TPAs

The automated approach to optimizing 340B savings & patient care while overcoming manufacturer restrictions NOTE: The purpose of this article is to highlight features and functionality any 340B platform needs to optimize a health system’s 340B savings and revenue. That said, we determined that the easiest way to report those features was to describe the … Read More

Is Your 340B Vendor A Partner Or A Parasite?

May 16, 2024340B, Covered Entities, Patient Eligibility, Retail / Outpatient Pharmacy, Specialty Drugs, Specialty Pharmacy

Why 340B vendors charging Percentage Of Revenue is wrong. The United States Congress established the 340B statute in 1992 to help non-profit hospitals fill-in the often-backbreaking revenue gaps inherent to their business models — enabling covered entities to replenish eligible prescriptions at significant savings. Savings which they can then pass-along to their patients, many of … Read More

The Case for Onsite Specialty Pharmacies in 340B Hospitals

April 4, 2024340B, 340B ESP, Bedside Prescription Delivery, Compliance, Covered Entities, Drug Manufacturer Restrictions, Meds To Beds, Prescription Discounts, Requirements, Specialty Drugs, Specialty Drugs, Specialty Pharmacy, Specialty Pharmacy

Why a Specialty Pharmacy? (Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. According to a report by The American Hospital Association, the number of Americans with chronic medical conditions will grow by a projected 9% between 2020 and 2030, an increase … Read More

Best Practices For A 340B Hospital Looking To Build An Onsite Specialty Pharmacy

March 28, 2024340B, Outpatient Tracking, Retail / Outpatient Pharmacy, Specialty Drugs, Specialty Pharmacy

VytlOne recently gathered three of its corporate executives for an in-depth discussion of how an eligible health system can optimize revenues from its 340B program and its retail pharmacy, to help build and fund an onsite specialty pharmacy. Below is a lightly-edited transcript of that discussion. NOTE: If you’d prefer to watch the complete video … Read More

For Pharmacist Mariana Elia, It’s All About The Relationship

March 20, 2024Meds To Beds, Pharmacy Careers, ProxsysRx Profile, Retail / Outpatient Pharmacy

If you’re a first-time patient of VytlOne’s pharmacy at Tallahassee Memorial Healthcare, and you want to get Mariana Elia talking, really talking, it helps to know key trigger words. Key words and phrases like “Hello,” “How are you?” and “Tell me about yourself.” All highly effective for starting a lively conversation, to be sure. But … Read More